Toggle navigation
Home
Search
Services
Blog
Contact
About
Preclinical Study of Recombinant Elastase Inhibitor
Mandle, Robert J.
Cbr Laboratories, Inc., Boston, MA, United States
Search 3 grants from Robert Mandle
Search grants from Cbr Laboratories, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Development of Gaze Control for Integration of Language and Visual Information in Deaf Children
Prevention of Lower Urinary Tract Symptoms in Women: Yale Bladder Health Clinical Center
Simulating Protein Structures, Complexes, And Dynamics
Neurodevelopment and Imaging among HIV-infected Children from the PREDICT study
Cyclohexanecarboxylic Acid and Polyketide Biosynthesis
Recently added grants:
New Treatments for Chronic Chagas Disease
The Role of Tumor-Targeted TLR5 Activation in Reversing Immune Checkpoint Therapy Resistance
Examining the Mechanisms of Immune Cell Infiltration and Organization in a Murine Model of Renal Cancer and in Primary Human Renal Tumors
Proteolytic control of DNA interstrand cross-link repair and genome integrity
Determining the function and mechanism of the MALAT1 long non-coding RNA in co-transcriptional splicing
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44HL052290-03
Application #
2229597
Study Section
Special Emphasis Panel (ZRG7-SSS-Z (18))
Project Start
1993-08-10
Project End
1998-04-30
Budget Start
1996-05-01
Budget End
1998-04-30
Support Year
3
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Cbr Laboratories, Inc.
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02115
Related projects
NIH 1996
R44 HL
Preclinical Study of Recombinant Elastase Inhibitor
Mandle, Robert J. / Cbr Laboratories, Inc.
NIH 1995
R44 HL
Preclinical Study of Recombinant Elastase Inhibitor
Mandle, Robert J. / Cbr Laboratories, Inc.
Comments
Be the first to comment on Robert Mandle's grant